Skip Navigation



JAC Advance Access published online on November 16, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl453
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/1/148    most recent
dkl453v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Moon, J. E.
Right arrow Articles by Murray, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moon, J. E.
Right arrow Articles by Murray, C. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received June 27, 2006
Revised September 27, 2006
Accepted October 13, 2006

Brief report

Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model

James E. Moon 1, Robert G. Rivard 1, Matthew E. Griffith 1, Roseanne A. Ressner 1, Suzanne McCall 1, Raven E. Reitstetter 1, Duane R. Hospenthal 1, and Clinton K. Murray 1 *

1 Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA; Department of Clinical Investigation, Brooke Army Medical Center, Fort Sam Houston, TX, USA

* To whom correspondence should be addressed.
Clinton K. Murray, E-mail: Clinton.Murray{at}amedd.army.mil


  Abstract

Objectives: Azithromycin is not associated with significant adverse effects or restricted usage in certain populations unlike standard antileptospirosis agents. In this study, the utility of short courses of azithromycin in treating or preventing leptospirosis was investigated in a lethal hamster model.

Methods: All hamsters were infected intraperitoneally with 105 leptospires. In experiment one, animals received 5 mg/kg of doxycycline or 10 mg/kg of azithromycin via intraperitoneal injection beginning on the second day after infection and continuing once daily for 1, 2, 3 or 5 days. In experiment two, animals received 1 or 2 day courses of azithromycin initiated 2 or 4 days following infection, or 4 days prior to infection.

Results: All untreated control animals died between the sixth and ninth day following infection. In experiment one, survival rates in the doxycycline groups were 0, 50, 80 and 100% for those animals treated for 1, 2, 3 and 5 days, respectively. Except for the 1 day treatment group (which had an 80% survival), there was 100% survival in all azithromycin-treated groups. In experiment two, all animals treated after infection survived until study completion. No animals survived with 1 day of therapy started 4 days prior to infection while only 20% survived if they received 2 days.

Conclusions: These results suggest short-course therapy with azithromycin, even started well after infection, is efficacious in preventing mortality from acute leptospirosis.

Keywords: treatment; prophylaxis; animal model.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
R. A. Ressner, M. E. Griffith, M. L. Beckius, G. Pimentel, R. S. Miller, K. Mende, S. L. Fraser, R. L. Galloway, D. R. Hospenthal, and C. K. Murray
Antimicrobial Susceptibilities of Geographically Diverse Clinical Human Isolates of Leptospira
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2750 - 2754.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.